These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 1876153)

  • 1. Immunological function in active heroin addicts and methadone-maintained former addicts: observations and possible mechanisms.
    Kreek MJ
    NIDA Res Monogr; 1990; 105():75-81. PubMed ID: 1876153
    [No Abstract]   [Full Text] [Related]  

  • 2. Immune function in heroin addicts and former heroin addicts in treatment: pre- and post-AIDS epidemic.
    Kreek MJ
    NIDA Res Monogr; 1990; 96():192-219. PubMed ID: 2233996
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immune status of unselected methadone maintained former heroin addicts.
    Kreek MJ; Khuri E; Flomenberg N; Albeck H; Ochshorn M
    Prog Clin Biol Res; 1990; 328():445-8. PubMed ID: 2304962
    [No Abstract]   [Full Text] [Related]  

  • 4. In vitro studies of the effect of methadone on natural killer cell activity.
    Ochshorn M; Novick DM; Kreek MJ
    Isr J Med Sci; 1990 Aug; 26(8):421-5. PubMed ID: 2401603
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Natural killer cell activity and lymphocyte subsets in parenteral heroin abusers and long-term methadone maintenance patients.
    Novick DM; Ochshorn M; Ghali V; Croxson TS; Mercer WD; Chiorazzi N; Kreek MJ
    J Pharmacol Exp Ther; 1989 Aug; 250(2):606-10. PubMed ID: 2788218
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Glucocorticoid negative feedback in methadone-maintained former heroin addicts with ongoing cocaine dependence: dose-response to dexamethasone suppression.
    Aouizerate B; Ho A; Schluger JH; Perret G; Borg L; Le Moal M; Piazza PV; Kreek MJ
    Addict Biol; 2006 Mar; 11(1):84-96. PubMed ID: 16759341
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of the opioid antagonist naloxone on human natural killer cell activity in vitro.
    Adelson MO; Novick DM; Khuri E; Albeck H; Hahn EF; Kreek MJ
    Isr J Med Sci; 1994 Sep; 30(9):679-84. PubMed ID: 8088979
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The alterations of immunological reactivity in heroin addicts and their normalization in patients maintained on methadone.
    Zajícová A; Wilczek H; Holán V
    Folia Biol (Praha); 2004; 50(1):24-8. PubMed ID: 15055740
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hepatitis B antigen and antibody in former heroin addicts on methadone maintenance: correlation with clinical and histological findings.
    Stimmel B; Vernace S; Heller E; Tobias H
    Proc Natl Conf Methadone Treat; 1973; 1():501-6. PubMed ID: 4808193
    [No Abstract]   [Full Text] [Related]  

  • 10. Significance of hypermacroglobulinemia in methadone maintained and other narcotic addicts.
    Cushman P
    Proc Natl Conf Methadone Treat; 1973; 1():515-22. PubMed ID: 4215976
    [No Abstract]   [Full Text] [Related]  

  • 11. Semen evaluation in heroin and methadone addicts.
    Ragni G; De Lauretis L; Gambaro V; Di Pietro R; Bestetti O; Recalcati F; Papetti C
    Acta Eur Fertil; 1985; 16(4):245-9. PubMed ID: 4072581
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Early appearance of Laennec's cirrhosis in former heroin addicts on methadone maintenance.
    Ryan JJ
    J Med Soc N J; 1980 Jun; 77(6):425-8. PubMed ID: 6930495
    [No Abstract]   [Full Text] [Related]  

  • 13. Buprenorphine and methadone maintenance treatment of heroin addicts preserves immune function.
    Sacerdote P; Franchi S; Gerra G; Leccese V; Panerai AE; Somaini L
    Brain Behav Immun; 2008 May; 22(4):606-13. PubMed ID: 18294814
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Difference in the behavior of T-lymphocyte populations in heroin and methadone addicts].
    Brugo MA; Guffanti A; Guzzetti S; Pedretti D; Stringhetti M; Confalonieri F
    Boll Ist Sieroter Milan; 1983; 62(6):517-23. PubMed ID: 6234006
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term followup studies of the medical status of adolescent former heroin addicts in chronic methadone maintenance treatment: liver disease and immune status.
    Kreek MJ; Khuri E; Fahey L; Miescher A; Arns P; Spagnoli D; Craig J; Millman R; Harte EH
    NIDA Res Monogr; 1986; 67():307-9. PubMed ID: 3092083
    [No Abstract]   [Full Text] [Related]  

  • 16. Alterations of immune functions in heroin addicts and heroin withdrawal subjects.
    Govitrapong P; Suttitum T; Kotchabhakdi N; Uneklabh T
    J Pharmacol Exp Ther; 1998 Aug; 286(2):883-9. PubMed ID: 9694946
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Absence of antibody to human immunodeficiency virus in long-term, socially rehabilitated methadone maintenance patients.
    Novick DM; Joseph H; Croxson TS; Salsitz EA; Wang G; Richman BL; Poretsky L; Keefe JB; Whimbey E
    Arch Intern Med; 1990 Jan; 150(1):97-9. PubMed ID: 2297301
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Benefits of retention in methadone maintenance and chronic medical conditions as risk factors for premature death among older heroin addicts.
    Fareed A; Casarella J; Amar R; Vayalapalli S; Drexler K
    J Psychiatr Pract; 2009 May; 15(3):227-34. PubMed ID: 19461397
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [What effects does methadone maintenance treatment have on the rehabilitation of heroin addicts?].
    Hermstad R; Johannessen G; Michelsen K
    Tidsskr Nor Laegeforen; 1998 Aug; 118(20):3139-41. PubMed ID: 9760857
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Opioid receptor imaging with positron emission tomography and [(18)F]cyclofoxy in long-term, methadone-treated former heroin addicts.
    Kling MA; Carson RE; Borg L; Zametkin A; Matochik JA; Schluger J; Herscovitch P; Rice KC; Ho A; Eckelman WC; Kreek MJ
    J Pharmacol Exp Ther; 2000 Dec; 295(3):1070-6. PubMed ID: 11082442
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.